Blood-Thinning Drug Xarelto May Cause Internal Bleeding

A blood-thinning drug, Xarelto, may cause internal bleeding. Xarelto, which is manufactured by Bayer and Johnson & Johnson, is a competitor to warfarin, a drug which has been used for about 50 years to prevent blood clots. Xarelto does not have an antidote to stop uncontrolled bleeding like warfarin does - if a patient's level of warfarin became too high, doctors could administer a dose of vitamin K. Also, the companies have not given information to doctors about how to count the drug's life-threatening bleeding effects.

The first lawsuit over Xarelto was filed earlier this year. In that lawsuit, the plaintiff claims that she was hospitalized in February 2013 for severe internal and gastrointestinal bleeding as a result of using the drug. The plaintiff also claims that Bayer and Johnson & Johnson never advised customers about the risks of using the drug. Since the first lawsuit was filed, many more lawsuits have been filed in relation to the drug.

Xarelto was approved in July 2011 to reduce the risk of blood clots, deep vein thrombosis, and pulmonary embolism after knee or hip replacement surgery. The drug was later approved to also treat abnormal heart rhythms. This approval came against the recommendations of FDA staff, who had serious safety concerns related to Xarelto. The FDA recently refused a third expansion of the use of the drug.

One of the supposed advantages of Xarelto is that it did not require the monitoring that was associated with warfarin, also known as Coumadin. However, it appears that the drug's use should be monitored, based on what has happed to patients. If you have been harmed by Xarelto, or another prescription drug, call the dangerous prescription drug attorneys at Kennedy Hodges at 888-894-0119, or contact us online. You may be entitled to compensation for your injuries.